Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||27.09 - 27.60|
|52 Week Range||15.05 - 28.67|
|PE Ratio (TTM)||15.49|
|Earnings Date||Oct 26, 2017 - Oct 30, 2017|
|Dividend & Yield||0.50 (1.77%)|
|1y Target Est||31.56|
Huntsman Corporation (HUN) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
Hedge funds have trimmed bets on a fall in shares of Clariant, just as activist investor Corvex increases pressure on the Swiss chemicals company to ditch a $20 billion M&A deal with rival Huntsman. The hedge funds' action shows some may have been squeezed by a rise in Clariant shares but also potentially points to some scepticism that Corvex will succeed in scuppering the deal. Clariant and Huntsman announced their merger in May valued at about $20 billion, but Corvex, run by New York-based Keith Meister, took a stake in Clariant to try to prevent it going ahead.
A group of U.S. activist investors threatened to vote against the proposed merger between Clariant and U.S.-based Huntsman, jeopardizing a deal that would create a $15 billion chemicals giant.